Arrowhead Pharmaceuticals Inc (ARWR) — Cash Flow-to-Debt Ratio
Arrowhead Pharmaceuticals Inc (ARWR) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of $20.49 Million could theoretically repay 0% of its total liabilities ($881.88 Million) in one year. Explore Arrowhead Pharmaceuticals Inc (ARWR) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Arrowhead Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1997–2025)
Historical debt coverage capacity for Arrowhead Pharmaceuticals Inc across 29 annual periods. Also explore ARWR total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Arrowhead Pharmaceuticals Inc (1997–2025)
Year-by-year debt coverage analysis for Arrowhead Pharmaceuticals Inc. For market capitalisation and broader financial context, see Arrowhead Pharmaceuticals Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | $179.55 Million | $947.02 Million | ▲ +138.9% |
| 2024 | -0.49x | $-462.85 Million | $948.74 Million | ▼ -51.7% |
| 2023 | -0.32x | $-153.89 Million | $478.39 Million | ▲ +35.3% |
| 2022 | -0.50x | $-136.13 Million | $273.60 Million | ▼ -187.6% |
| 2021 | 0.57x | $171.22 Million | $301.33 Million | ▲ +136.2% |
| 2020 | -1.57x | $-95.39 Million | $60.72 Million | ▼ -196.1% |
| 2019 | 1.64x | $173.03 Million | $105.81 Million | ▲ +156.7% |
| 2018 | -2.88x | $-47.22 Million | $16.37 Million | ▼ -179.0% |
| 2017 | -1.03x | $-23.94 Million | $23.16 Million | ▲ +46.8% |
| 2016 | -1.94x | $-64.43 Million | $33.15 Million | ▲ +33.0% |
| 2015 | -2.90x | $-65.71 Million | $22.65 Million | ▼ -37.9% |
| 2014 | -2.10x | $-35.42 Million | $16.83 Million | ▼ -28.2% |
| 2013 | -1.64x | $-19.03 Million | $11.59 Million | ▲ +17.4% |
| 2012 | -1.99x | $-15.34 Million | $7.72 Million | ▼ -22.6% |
| 2011 | -1.62x | $-5.39 Million | $3.32 Million | ▲ +9.9% |
| 2010 | -1.80x | $-7.70 Million | $4.28 Million | ▲ +66.5% |
| 2009 | -5.37x | $-15.28 Million | $2.84 Million | ▲ +3.6% |
| 2008 | -5.57x | $-27.58 Million | $4.95 Million | ▲ +20.7% |
| 2007 | -7.03x | $-23.87 Million | $3.40 Million | ▼ -38.7% |
| 2006 | -5.07x | $-14.79 Million | $2.92 Million | ▲ +43.0% |
| 2005 | -8.89x | $-9.10 Million | $1.02 Million | ▼ -164.8% |
| 2004 | -3.36x | $-2.31 Million | $689.70K | ▼ -104.8% |
| 2003 | -1.64x | $-157.60K | $96.18K | ▼ -2399.4% |
| 2002 | -0.07x | $-105.83K | $1.61 Million | ▼ -8.2% |
| 2001 | -0.06x | $-81.81K | $1.35 Million | ▲ +9.7% |
| 2000 | -0.07x | $-80.09K | $1.19 Million | ▼ -105.3% |
| 1999 | -0.03x | $-35.22K | $1.08 Million | ▼ -92.0% |
| 1998 | -0.02x | $-46.15K | $2.71 Million | ▼ -1100.9% |
| 1997 | 0.00x | $4.56K | $2.68 Million | — |